Form 4: Fractyl Health CEO Harith Rajagopalan Executes Stock Options and Sells Shares

CEO Harith Rajagopalan exercised stock options and sold shares of Fractyl Health, Inc. on January 30 and 31, 2025, according to a Form 4 filing with the SEC.

Summary

• Harith Rajagopalan, CEO of Fractyl Health, Inc., engaged in transactions involving the company's stock on January 30 and 31, 2025.
• On both dates, Rajagopalan exercised stock options to acquire shares of common stock at a price of $1.70 per share.
• Simultaneously, Rajagopalan sold shares of common stock on the open market at weighted average prices of $1.9476 and $1.816 on January 30 and 31, 2025, respectively.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan established on September 12, 2024.
• Following these transactions, Rajagopalan directly owns 491,329 shares of common stock and indirectly owns 593,010 shares through various irrevocable and family trusts.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's future.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially impacting the stock price, although these sales were pre-planned under a 10b5-1 trading plan.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the change in the number of shares held by the CEO.
• The impact is likely minimal as the sales were pre-planned.

Key Dates